AC2993 (exenatide)Potential Treatment for Type 2 Diabetes

• Unique, potent glucose-lowering agent

  • Active when glucose is high; inactive when glucose is low
  • Restores more normal beta-cell response
  • Potential to address the spectrum of type 2 diabetes

• Additional possible upsides:

  • Sustained release (LAR) formulation in Phase 2
  • Improved weight management in type 2 diabetes
  • Positive beta-cell effects

Previous slide

Next slide

Back to first slide

View graphic version